NCT02531607Active, not recruiting
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds Biomarkers in Bile and Serum in the Diagnosis of Malignant Biliary Strictures
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
This is a non-randomized natural history protocol in which patients undergoing surgery or endoscopy for suspected/ diagnosed pancreaticobiliary strictures are assigned to a) control (chronic pancreatitis, no pancreatic neoplasm, primary sclerosing cholangitis), b) non-carcinoma (bile duct stones, papillary stenosis, ), c) carcinoma non-pancreatic (ampullary and distal bile duct or cholangiocarcinoma) and d) pancreatic ductal adenocarcinoma (pancreatic cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 11 Feb 2015
- Start date
- 13 Nov 2014
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- AdventHealth
- Diseases
- Pancreatic cancer
- NCT number
- NCT02531607
What you commit to
- Study type: Observational
- Planned participants: 500
- From 13 Nov 2014 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Post-bariatric surgery, hepaticojejunostomy and Bilroth II patients undergoing ERCP.
Age
- Age: \<18years old
Other
- Pregnant women
- Not scheduled for endoscopic procedures for clinical reasons
- No clinical or image data suggestive of need for clinical intervention (Endoscopy)
- Not willing or able to sign informed consent..
Who the study is looking for
- Screening Criteria for Potential Participants in the Study
- Age: ≥18years old
- Treatment: scheduled for clinical reason to undergo an ERCP at the CIE
- Suspected of having biliary or pancreatic disease other than cancer (chronic pancreatitis, benign biliary strictures, post-liver transplant strictures, common bile duct stones, sphincter of Oddi dysfunction or suspected of having pancreatic or peri-ampullary malignancy (including pancreatic ductal adenocarcinoma, distal cholangiocarcinoma, ampullary carcinoma, duodenal, carcinoma
- Clinical or image data suggestive of pancreatic disease or the need for gastrointestinal or pancreatic inspection.
- Willing and mentally able to provide consent
Age in the registry: 19 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AdventHealth Coordinator of this site? Confirm its status | Orlando | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.